Evotec enters partnership with Vienna start-up
Quantro exploits innovative functional-genetic and transcriptomic technologies to address “undruggable” targets
22-Jul-2020 -
Evotec SE announced that the Company has entered into a comprehensive partnership with the recently established QUANTRO Therapeutics GmbH, a research-based biotech company based in Vienna, Austria, that strives to discover and develop novel therapeutics interfering with disease-causing ...
cancer
drug development
drug discovery
+2